Travere Therapeutics
The Executive Director, CMC Diligence leads technical assessments for clinical and commercial-stage assets associated with external business development opportunities. This role evaluates manufacturing, supply chain, and commercial readiness risks to support licensing, acquisition, and partnership decisions. The position requires deep expertise in CMC across small molecules, biologics, and gene therapies, collaborating with cross-functional leaders to integrate technical findings into strategic transaction outcomes.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2020
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall
1 day ago
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)
3 days ago
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Travere Therapeutics.
37% above the average for this role
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory
2 weeks ago
Associate Director, Regulatory CMC
Praxis Precision Medicines, Inc.
Associate Director, CMC Regulatory Affairs
AbCellera
Senior Director, Regulatory CMC
Eli Lilly and Company
Senior Consultant
Syner-G
Senior Director, Regulatory Affairs CMC
Zenas BioPharma
Senior STEM Content Analyst- CMC (Small Molecules/Biologics)
Clarivate